Recombinant Anti-VEGFB x Anti-VEGF Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-VEGFB antibody variable domain is fused to CH1 and the other scFv from an anti-VEGF antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can block two proangiogenics simultaneously. It is designed for the research of Cancers therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY